KYORIN Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
KYORIN Pharmaceutical has a total shareholder equity of ¥126.6B and total debt of ¥20.8B, which brings its debt-to-equity ratio to 16.4%. Its total assets and total liabilities are ¥178.9B and ¥52.4B respectively. KYORIN Pharmaceutical's EBIT is ¥4.9B making its interest coverage ratio -11.1. It has cash and short-term investments of ¥19.1B.
Key information
16.4%
Debt to equity ratio
JP¥20.79b
Debt
Interest coverage ratio | -11.1x |
Cash | JP¥19.15b |
Equity | JP¥126.58b |
Total liabilities | JP¥52.37b |
Total assets | JP¥178.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4569's short term assets (¥120.5B) exceed its short term liabilities (¥47.6B).
Long Term Liabilities: 4569's short term assets (¥120.5B) exceed its long term liabilities (¥4.8B).
Debt to Equity History and Analysis
Debt Level: 4569's net debt to equity ratio (1.3%) is considered satisfactory.
Reducing Debt: 4569's debt to equity ratio has reduced from 19.5% to 16.4% over the past 5 years.
Debt Coverage: 4569's debt is not well covered by operating cash flow (20%).
Interest Coverage: 4569 earns more interest than it pays, so coverage of interest payments is not a concern.